Sophia Delicou: Recognizing Missed Clues and Advancing Early Clinical Suspicion of Adult Haemoglobinopathies
Sophia Delicou, Head of Thalassemia and Sickle Cell Unit, Head of the Expertise Center of Hemoglobin Diseases and Their Complications at Hippokrateio General Hospital, shared on LinkedIn about a recent article she and her colleagues co-authored, published in European Journal of Haematology, adding:
”We are pleased to share our team’s latest publication in the European Journal of Haematology:
‘Delayed Diagnosis of Adult Haemoglobinopathies: An Exploratory Retrospective Study of Diagnostic Trajectories and a Preliminary Clinical Suspicion Framework’
This work highlights an important and often under-recognized clinical challenge: the delayed diagnosis of haemoglobinopathies in adulthood.
Patients are frequently misclassified as having iron deficiency anaemia, leading to inappropriate iron supplementation, prolonged diagnostic uncertainty, and delayed access to appropriate care and genetic counselling.
In our retrospective pilot study, key recurring features included persistent microcytosis, evidence of haemolysis, and lack of response to iron therapy.
We also propose a preliminary clinical suspicion framework, the Haemoglobinopathy Suspicion Score (HSS), as a hypothesis-generating tool requiring further validation.
The key message fully aligned with the mission of the Thalassaemia International Federation (TIF) is clear: early clinical suspicion of haemoglobinopathies in adults is essential to reduce diagnostic delays and improve patient outcomes.
Congratulations to the entire multidisciplinary team for this important contribution.”
Title: Delayed Diagnosis of Adult Haemoglobinopathies: An Exploratory Retrospective Study of Diagnostic Trajectories and a Preliminary Clinical Suspicion Framework
Authors: Sophia Delicou, Aikaterini Poulaki, Iliana Mani, Christos Savvidis, Aikaterini Xydaki, Maria Moraki, Constantina Aggeli, Ioannis Ilias, John Koskinas

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 16, 2026, 10:31Erhabor Osaro: Critical Issues to Consider During the Clinical Blood Transfusion Process
-
Aug 16, 2026, 10:14Juan Manuel Cisneros Carrasco: The Architects Behind the Blood Donation System
-
Aug 16, 2026, 10:06Honoring the Life and Legacy of Dr. Reed Pyeritz – GADA Canada
-
Aug 16, 2026, 09:51Javier Amador-Castañeda: When a 32 Percent Reduction Tells Only Part of the Story
-
Aug 16, 2026, 09:33Anıl Güneş: The Unseen Threat – How Global Climate Change Impacts Cardiovascular Health
-
Aug 16, 2026, 09:09Robert John Nesbitt: Can We Prevent Stroke Without Increasing Bleeding Risk
-
Aug 16, 2026, 06:19Dennis Wolf: Is ZEUS the End of Anti-Inflammatory Therapy in Atherosclerosis?
-
Aug 16, 2026, 06:05Nicolas Hubacz: A New Target for Stroke Recovery
-
Aug 15, 2026, 19:30José Luis Neyro: E4 and DRSP Reduce Hirsutism While Showing Comparable Effects on Thrombin Generation